Covid vaccine: South Korea reports blood clot case after AstraZeneca vaccine
Symptoms curable if detected early and treated properly, says disease agency chief
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Medics in South Korea have reported the country’s first case of rare blood clotting linked to the AstraZeneca coronavirus vaccine.
A medical facility worker in his 30s was taken to hospital on 12 May after receiving the jab on 27 April. He developed a headache on 9 May before falling seriously ill, and also suffered muscle cramps.
Jeong Eun-kyeong, director of the Korea Disease Control and Prevention Agency (KDCA), said in a statement: “His condition has improved since then and we understand there is no big problem though he still needs monitoring.”
The symptoms of blood clotting are curable if detected early and treated properly, she added.
About 3.27 million people in South Korea have been given at least one dose of the AstraZeneca vaccine so far. Seoul limited its use to the over-30s following the initial reports of blood clotting elsewhere in the world.
Those reports have mainly concerned a type of blood clot called cerebral venous sinus thrombosis. The condition has been seen in combination with low blood platelet levels, called thrombocytopenia.
Medical regulators in the US and Europe have concluded that there appears to be a link between AstraZeneca's vaccine, as well as one made by Johnson & Johnson, and the clots, but they say the shots are safe and that the benefits of being vaccinated outweigh the risks.
AstraZeneca has said it is working to understand individual cases and “possible mechanisms that could explain these extremely rare events”, while J&J has said that no clear causal relationship has been established between the vaccine and the clots.
The KDCA reported 430 new coronavirus cases as of Sunday, for a total of 140,340 cases with 1,959 deaths.
Additional reporting by Reuters
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments